Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction.

Behnes M, Papassotiriou J, Walter T, Fiedler E, Sauer T, Lang S, Elmas E, Hoffmann U, Borggrefe M, Brueckmann M.

Clin Chem Lab Med. 2008;46(2):204-11.

PMID:
18076360
2.

Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.

Walter T, Brueckmann M, Lang S, Sauer T, Fiedler E, Papassotiriou J, Behnes M, Elmas E, Borggrefe M, Bertsch T.

Clin Lab. 2010;56(7-8):303-9.

PMID:
20857894
3.

Pro-adrenomedullin, pro-endothelin-1, procalcitonin, C-reactive protein and mortality risk in critically ill children: a prospective study.

Rey C, García-Hernández I, Concha A, Martínez-Camblor P, Botrán M, Medina A, Prieto B, López-Herce J.

Crit Care. 2013 Oct 16;17(5):R240. doi: 10.1186/cc13064.

4.

Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD.

Stolz D, Christ-Crain M, Morgenthaler NG, Miedinger D, Leuppi J, Müller C, Bingisser R, Struck J, Müller B, Tamm M.

Chest. 2008 Aug;134(2):263-72. doi: 10.1378/chest.08-0047. Epub 2008 May 19.

PMID:
18490402
5.

Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients.

Haaf P, Twerenbold R, Reichlin T, Faoro J, Reiter M, Meune C, Steuer S, Bassetti S, Ziller R, Balmelli C, Campodarve I, Zellweger C, Kilchenmann A, Irfan A, Papassotiriou J, Drexler B, Mueller C.

Int J Cardiol. 2013 Sep 30;168(2):1048-55. doi: 10.1016/j.ijcard.2012.10.025. Epub 2012 Nov 27.

PMID:
23199555
6.

Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL.

J Am Coll Cardiol. 2007 Apr 10;49(14):1525-32. Epub 2007 Mar 26.

7.

Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients.

Lundberg OH, Bergenzaun L, Rydén J, Rosenqvist M, Melander O, Chew MS.

Crit Care. 2016 Jun 9;20(1):178. doi: 10.1186/s13054-016-1361-y.

8.

Utility of C-terminal proendothelin in the early diagnosis and risk stratification of patients with suspected acute myocardial infarction.

Haaf P, Zellweger C, Reichlin T, Zbinden A, Wildi K, Mosimann T, Twerenbold R, Reiter M, Balmelli C, Freidank H, Gimenez MR, Peter F, Freese M, Stelzig C, Hartmann B, Dinter C, Osswald S, Mueller C.

Can J Cardiol. 2014 Feb;30(2):195-203. doi: 10.1016/j.cjca.2013.11.020. Epub 2013 Nov 23.

PMID:
24461921
9.

Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.

Adlbrecht C, Hülsmann M, Strunk G, Berger R, Mörtl D, Struck J, Morgenthaler NG, Bergmann A, Jakowitsch J, Maurer G, Lang IM, Pacher R.

Eur J Heart Fail. 2009 Apr;11(4):361-6. doi: 10.1093/eurjhf/hfp004. Epub 2009 Feb 3.

10.

Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.

Dhillon OS, Khan SQ, Narayan HK, Ng KH, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL.

J Am Coll Cardiol. 2010 Jul 6;56(2):125-33. doi: 10.1016/j.jacc.2010.01.060.

11.

Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis.

Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Müller B.

Endothelium. 2007 Nov-Dec;14(6):345-51.

12.

Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study.

Seissler J, Feghelm N, Then C, Meisinger C, Herder C, Koenig W, Peters A, Roden M, Lechner A, Kowall B, Rathmann W.

Eur J Endocrinol. 2012 Dec;167(6):847-53. doi: 10.1530/EJE-12-0472. Epub 2012 Sep 20.

13.

MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.

Tzikas S, Keller T, Ojeda FM, Zeller T, Wild PS, Lubos E, Kunde J, Baldus S, Bickel C, Lackner KJ, Münzel TF, Blankenberg S.

Heart. 2013 Mar;99(6):388-95. doi: 10.1136/heartjnl-2012-302956. Epub 2012 Dec 4.

PMID:
23213173
14.

Plasma concentrations of novel cardiac biomarkers before and after hemodialysis session.

Mueller T, Gegenhuber A, Kronabethleitner G, Leitner I, Haltmayer M, Dieplinger B.

Clin Biochem. 2015 Nov;48(16-17):1163-6. doi: 10.1016/j.clinbiochem.2015.07.031. Epub 2015 Jul 29.

15.

Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.

Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T; German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group..

Am J Respir Crit Care Med. 2010 Dec 1;182(11):1426-34. doi: 10.1164/rccm.201003-0415OC. Epub 2010 Jul 16.

PMID:
20639437
16.

Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.

Travaglino F, Russo V, De Berardinis B, Numeroso F, Catania P, Cervellin G, Nigra SG, Geraci F, Bressan MA, Guerrini S, Cavazza M, Folli C, Monzani V, Battista S, Mengozzi G, Noto P, Carpinteri G, Semplicini A, Stella F, Ingrassia S, Moscatelli P, Giuntini P, Salerno G, Cardelli P, Di Somma S.

Am J Emerg Med. 2014 Apr;32(4):334-41. doi: 10.1016/j.ajem.2013.12.045. Epub 2014 Jan 3.

PMID:
24559907
17.

Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.

Bahrmann P, Bahrmann A, Hofner B, Christ M, Achenbach S, Sieber CC, Bertsch T.

Eur Heart J Acute Cardiovasc Care. 2015 Apr;4(2):137-47. doi: 10.1177/2048872614541904. Epub 2014 Jul 7.

PMID:
25002708
18.

Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study.

Potocki M, Breidthardt T, Reichlin T, Morgenthaler NG, Bergmann A, Noveanu M, Schaub N, Uthoff H, Freidank H, Buser L, Bingisser R, Christ M, Mebazaa A, Mueller C.

Crit Care. 2009;13(4):R122. doi: 10.1186/cc7975. Epub 2009 Jul 23.

19.

Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Elmas E, Doesch C, Fluechter S, Freundt M, Weiss C, Lang S, Kälsch T, Haghi D, Papassotiriou J, Kunde J, Schoenberg SO, Borggrefe M, Papavassiliu T.

Int J Cardiovasc Imaging. 2011 Apr;27(4):547-56. doi: 10.1007/s10554-010-9704-2. Epub 2010 Sep 26.

PMID:
20872251
20.

Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.

Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Müller B.

Crit Care. 2005;9(6):R816-24. Epub 2005 Nov 15.

Supplemental Content

Support Center